Role of Bioactive Compounds, Novel Drug Delivery Systems, and Polyherbal Formulations in the Management of Rheumatoid Arthritis


Cite item

Full Text

Abstract

Rheumatoid Arthritis (RA) is an autoimmune disorder that generally causes joint synovial inflammation as well as gradual cartilage and degenerative changes, resulting in progressive immobility. Cartilage destruction induces synovial inflammation, including synovial cell hyperplasia, increased synovial fluid, and synovial pane development. This phenomenon causes articular cartilage damage and joint alkalosis. Traditional medicinal system exerts their effect through several cellular mechanisms, including inhibition of inflammatory mediators, oxidative stress suppression, cartilage degradation inhibition, increasing antioxidants and decreasing rheumatic biomarkers. The medicinal plants have yielded a variety of active constituents from various chemical categories, including alkaloids, triterpenoids, steroids, glycosides, volatile oils, flavonoids, lignans, coumarins, terpenes, sesquiterpene lactones, anthocyanins, and anthraquinones. This review sheds light on the utilization of medicinal plants in the treatment of RA. It explains various phytoconstituents present in medicinal plants and their mechanism of action against RA. It also briefs about the uses of polyherbal formulations (PHF), which are currently in the market and the toxicity associated with the use of medicinal plants and PHF, along with the limitations and research gaps in the field of PHF. This review paper is an attempt to understand various mechanistic approaches employed by several medicinal plants, their possible drug delivery systems and synergistic effects for curing RA with minimum side effects.

About the authors

Neha Rana

KIET School of Pharmacy, KIET Group of Institutions

Email: info@benthamscience.net

Piyush Gupta

Department of Chemistry,, SRM Institute of Science and Technology, Faculty of Engineering and Technology

Author for correspondence.
Email: info@benthamscience.net

Hridayanand Singh

, Dr. K. N. Modi Institute of Pharmaceutical Education and Research

Email: info@benthamscience.net

Kandasamy Nagarajan

KIET School of Pharmacy, KIET Group of Institutions

Email: info@benthamscience.net

References

  1. Sharma, A.; Kudesia, P.; Shi, Q.; Gandhi, R. Anxiety and depression in patients with osteoarthritis: Impact and management challenges. Open Access Rheumatol., 2016, 8(8), 103-113. doi: 10.2147/OARRR.S93516 PMID: 27843376
  2. Majithia, V.; Geraci, S.A. Rheumatoid arthritis: Diagnosis and management. Am. J. Med., 2007, 120(11), 936-939. doi: 10.1016/j.amjmed.2007.04.005 PMID: 17976416
  3. Huizinga, T.W.J.; Pincus, T. Rheumatoid Arthritis. Ann. Intern. Med., 2010, 153(1), ITC1-1. doi: 10.7326/0003-4819-153-1-201007060-01001 PMID: 20621898
  4. Edwards, J.C.W. Szczepański, L.; Szechiński, J.; Filipowicz-Sosnowska, A.; Emery, P.; Close, D.R.; Stevens, R.M.; Shaw, T. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med., 2004, 350(25), 2572-2581. doi: 10.1056/NEJMoa032534 PMID: 15201414
  5. Aletaha, D.; Smolen, J.S. Diagnosis and management of rheumatoid arthritis. JAMA, 2018, 320(13), 1360-1372. doi: 10.1001/jama.2018.13103 PMID: 30285183
  6. Genovese, M.C.; Fleischmann, R.; Combe, B.; Hall, S.; Rubbert-Roth, A.; Zhang, Y.; Zhou, Y.; Mohamed, M.E.F.; Meerwein, S.; Pangan, A.L. Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): A double-blind, randomised controlled phase 3 trial. Lancet, 2018, 391(10139), 2513-2524. doi: 10.1016/S0140-6736(18)31116-4 PMID: 29908670
  7. Genovese, M.C.; Kalunian, K.; Gottenberg, J.E.; Mozaffarian, N.; Bartok, B.; Matzkies, F.; Gao, J.; Guo, Y.; Tasset, C.; Sundy, J.S.; de Vlam, K.; Walker, D.; Takeuchi, T. Effect of filgotinib vs placebo on clinical response in patients with moderate to severe rheumatoid arthritis refractory to disease-modifying antirheumatic drug therapy: The FINCH 2 randomized clinical trial. JAMA, 2019, 322(4), 315-325. doi: 10.1001/jama.2019.9055 PMID: 31334793
  8. Kivitz, A.J.; Gutierrez-Ureña, S.R.; Poiley, J.; Genovese, M.C.; Kristy, R.; Shay, K.; Wang, X.; Garg, J.P.; Zubrzycka-Sienkiewicz, A. Peficitinib, a JAK Inhibitor, in the treatment of moderate-to-severe rheumatoid arthritis in patients with an inadequate response to methotrexate. Arthritis Rheumatol., 2017, 69(4), 709-719. doi: 10.1002/art.39955 PMID: 27748083
  9. Klareskog, L.; van der Heijde, D.; de Jager, J.P.; Gough, A.; Kalden, J.; Malaise, M.; Mola, E.M.; Pavelka, K.; Sany, J.; Settas, L.; Wajdula, J.; Pedersen, R.; Fatenejad, S.; Sanda, M. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: Double-blind randomised controlled trial. Lancet, 2004, 363(9410), 675-681. doi: 10.1016/S0140-6736(04)15640-7 PMID: 15001324
  10. Emery, P.; Breedveld, F.C.; Hall, S.; Durez, P.; Chang, D.J.; Robertson, D.; Singh, A.; Pedersen, R.D.; Koenig, A.S.; Freundlich, B. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): A randomised, double-blind, parallel treatment trial. Lancet, 2008, 372(9636), 375-382. doi: 10.1016/S0140-6736(08)61000-4 PMID: 18635256
  11. Lin, Y.J.; Anzaghe, M.; Schülke, S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells, 2020, 9(4), 880. doi: 10.3390/cells9040880 PMID: 32260219
  12. Ma, L.; Cranney, A.; Holroyd-Leduc, J.M. Acute monoarthritis: What is the cause of my patient’s painful swollen joint? CMAJ, 2009, 180(1), 59-65. doi: 10.1503/cmaj.080183 PMID: 19124791
  13. McInnes, I.B.; Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med., 2011, 365(23), 2205-2219. doi: 10.1056/NEJMra1004965 PMID: 22150039
  14. Nagarajan, K.; Singh, A.; Tripathi, M.; Batra, U.; Grover, P.; Kapoor, G.; Goel, R.; Chauhan, S.; Malhotra, A. Evaluation of in-vitro antioxidant potency of Arnebia nobilis root extract. Pharmacologyonline, 2021, 3, 1015-1029. Available from: http://pharmacologyonline.silae.it/
  15. Rudan, I.; Sidhu, S.; Papana, A.; Meng, S.J.; Xin-Wei, Y.; Wang, W.; Campbell-Page, R.M.; Demaio, A.R.; Nair, H.; Sridhar, D.; Theodoratou, E.; Dowman, B.; Adeloye, D.; Majeed, A.; Car, J.; Campbell, H.; Wang, W.; Chan, K.Y. Prevalence of rheumatoid arthritis in low- and middle-income countries: A systematic review and analysis. J. Glob. Health, 2015, 5(1), 010409. doi: 10.7189/jogh.05.010409 PMID: 25969732
  16. Padyukov, L. Genetics of rheumatoid arthritis. Semin. Immunopathol., 2022, 44(1), 47-62. doi: 10.1007/s00281-022-00912-0 PMID: 35088123
  17. Khanna, N.; Kumar, A.; Pawar, S.V. A review on rheumatoid arthritis interventions and current developments. Curr. Drug Targets, 2021, 22(4), 463-483. doi: 10.2174/1389450121999201125200558 PMID: 33243118
  18. Cutolo, M.; Villaggio, B.; Craviotto, C.; Pizzorni, C.; Seriolo, B.; Sulli, A. Sex hormones and rheumatoid arthritis. Autoimmun. Rev., 2002, 1(5), 284-289. doi: 10.1016/S1568-9972(02)00064-2 PMID: 12848982
  19. Raychaudhuri, S.; Sandor, C.; Stahl, E.A.; Freudenberg, J.; Lee, H.S.; Jia, X.; Alfredsson, L.; Padyukov, L.; Klareskog, L.; Worthington, J.; Siminovitch, K.A.; Bae, S.C.; Plenge, R.M.; Gregersen, P.K.; de Bakker, P.I.W. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet., 2012, 44(3), 291-296. doi: 10.1038/ng.1076 PMID: 22286218
  20. Meng, W.; Zhu, Z.; Jiang, X.; Too, C.L.; Uebe, S.; Jagodic, M.; Kockum, I.; Murad, S.; Ferrucci, L.; Alfredsson, L.; Zou, H.; Klareskog, L.; Feinberg, A.P.; Ekström, T.J.; Padyukov, L.; Liu, Y. DNA methylation mediates genotype and smoking interaction in the development of anti-citrullinated peptide antibody-positive rheumatoid arthritis. Arthritis Res. Ther., 2017, 19(1), 71. doi: 10.1186/s13075-017-1276-2 PMID: 28356135
  21. Krishnamurthy, A.; Joshua, V.; Haj Hensvold, A.; Jin, T.; Sun, M.; Vivar, N.; Ytterberg, A.J.; Engström, M.; Fernandes-Cerqueira, C.; Amara, K.; Magnusson, M.; Wigerblad, G.; Kato, J.; Jiménez-Andrade, J.M.; Tyson, K.; Rapecki, S.; Lundberg, K.; Catrina, S.B.; Jakobsson, P.J.; Svensson, C.; Malmström, V.; Klareskog, L.; Wähämaa, H.; Catrina, A.I. Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss. Ann. Rheum. Dis., 2016, 75(4), 721-729. doi: 10.1136/annrheumdis-2015-208093 PMID: 26612338
  22. Wigerblad, G.; Bas, D.B.; Fernades-Cerqueira, C.; Krishnamurthy, A.; Nandakumar, K.S.; Rogoz, K.; Kato, J.; Sandor, K.; Su, J.; Jimenez-Andrade, J.M.; Finn, A.; Bersellini Farinotti, A.; Amara, K.; Lundberg, K.; Holmdahl, R.; Jakobsson, P-J.; Malmström, V.; Catrina, A.I.; Klareskog, L.; Svensson, C.I. Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism. Ann. Rheum. Dis., 2016, 75(4), 730-738. doi: 10.1136/annrheumdis-2015-208094 PMID: 26613766
  23. Burmester, G.R.; Dimitriu-Bona, A.; Waters, S.J.; Winchester, R.J. Identification of three major synovial lining cell populations by monoclonal antibodies directed to Ia antigens and antigens associated with monocytes/macrophages and fibroblasts. Scand. J. Immunol., 1983, 17(1), 69-82. doi: 10.1111/j.1365-3083.1983.tb00767.x PMID: 6573767
  24. Hueber, A.J.; Asquith, D.L.; Miller, A.M.; Reilly, J.; Kerr, S.; Leipe, J.; Melendez, A.J.; McInnes, I.B. Mast cells express IL-17A in rheumatoid arthritis synovium. J. Immunol., 2010, 184(7), 3336-3340. doi: 10.4049/jimmunol.0903566 PMID: 20200272
  25. Zvaifler, N.J.; Steinman, R.M.; Kaplan, G.; Lau, L.L.; Rivelis, M. Identification of immunostimulatory dendritic cells in the synovial effusions of patients with rheumatoid arthritis. J. Clin. Invest., 1985, 76(2), 789-800. doi: 10.1172/JCI112036 PMID: 3875632
  26. Yang, Z.; Shen, Y.; Oishi, H.; Matteson, E.L.; Tian, L.; Goronzy, J.J.; Weyand, C.M. Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis. Sci. Transl. Med., 2016, 8(331), 331ra38. doi: 10.1126/scitranslmed.aad7151 PMID: 27009267
  27. Sabeh, F.; Fox, D.; Weiss, S.J. Membrane-type I matrix metalloproteinase-dependent regulation of rheumatoid arthritis synoviocyte function. J. Immunol., 2010, 184(11), 6396-6406. doi: 10.4049/jimmunol.0904068 PMID: 20483788
  28. Okamoto, K.; Nakashima, T.; Shinohara, M.; Negishi-Koga, T.; Komatsu, N.; Terashima, A.; Sawa, S.; Nitta, T.; Takayanagi, H. Osteoimmunology: The conceptual framework unifying the immune and skeletal systems. Physiol. Rev., 2017, 97(4), 1295-1349. doi: 10.1152/physrev.00036.2016 PMID: 28814613
  29. Harre, U.; Georgess, D.; Bang, H.; Bozec, A.; Axmann, R.; Ossipova, E.; Jakobsson, P.J.; Baum, W.; Nimmerjahn, F.; Szarka, E.; Sarmay, G.; Krumbholz, G.; Neumann, E.; Toes, R.; Scherer, H.U.; Catrina, A.I.; Klareskog, L.; Jurdic, P.; Schett, G. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J. Clin. Invest., 2012, 122(5), 1791-1802. doi: 10.1172/JCI60975 PMID: 22505457
  30. Arts, E.E.A.; Fransen, J.; Den Broeder, A.A.; van Riel, P.L.C.M.; Popa, C.D. Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: A time-dependent Cox regression analysis in a large cohort study. Ann. Rheum. Dis., 2017, 76(10), 1693-1699. doi: 10.1136/annrheumdis-2016-210997 PMID: 28606965
  31. Gaby, A.R. Alternative treatments for rheumatoid arthritis. Altern. Med. Rev., 1999, 4(6), 392-402. PMID: 10608912
  32. Ong, C.K.S.; Lirk, P.; Tan, C.H.; Seymour, R.A. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin. Med. Res., 2007, 5(1), 19-34. doi: 10.3121/cmr.2007.698 PMID: 17456832
  33. Combe, B.; Landewe, R.; Daien, C.I.; Hua, C.; Aletaha, D.; Álvaro-Gracia, J.M.; Bakkers, M.; Brodin, N.; Burmester, G.R.; Codreanu, C.; Conway, R.; Dougados, M.; Emery, P.; Ferraccioli, G.; Fonseca, J.; Raza, K.; Silva-Fernández, L.; Smolen, J.S.; Skingle, D.; Szekanecz, Z.; Kvien, T.K.; van der Helm-van Mil, A.; van Vollenhoven, R. 2016 update of the EULAR recommendations for the management of early arthritis. Ann. Rheum. Dis., 2017, 76(6), 948-959. doi: 10.1136/annrheumdis-2016-210602 PMID: 27979873
  34. Liu, D.; Ahmet, A.; Ward, L.; Krishnamoorthy, P.; Mandelcorn, E.D.; Leigh, R.; Brown, J.P.; Cohen, A.; Kim, H. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin. Immunol., 2013, 9(1), 30. doi: 10.1186/1710-1492-9-30 PMID: 23947590
  35. Whittle, S.L.; Colebatch, A.N.; Buchbinder, R.; Edwards, C.J.; Adams, K.; Englbrecht, M.; Hazlewood, G.; Marks, J.L.; Radner, H.; Ramiro, S.; Richards, B.L.; Tarner, I.H.; Aletaha, D.; Bombardier, C.; Landewé, R.B.; Müller-Ladner, U.; Bijlsma, J.W.J.; Branco, J.C.; Bykerk, V.P.; da Rocha Castelar Pinheiro, G.; Catrina, A.I.; Hannonen, P.; Kiely, P.; Leeb, B.; Lie, E.; Martinez-Osuna, P.; Montecucco, C.; Ostergaard, M.; Westhovens, R.; Zochling, J.; van der Heijde, D. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: Integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative. Rheumatology, 2012, 51(8), 1416-1425. doi: 10.1093/rheumatology/kes032 PMID: 22447886
  36. Smolen, J.S.; Landewé, R.; Breedveld, F.C.; Dougados, M.; Emery, P.; Gaujoux-Viala, C.; Gorter, S.; Knevel, R.; Nam, J.; Schoels, M.; Aletaha, D.; Buch, M.; Gossec, L.; Huizinga, T.; Bijlsma, J.W.J.W.; Burmester, G.; Combe, B.; Cutolo, M.; Gabay, C.; Gomez-Reino, J.; Kouloumas, M.; Kvien, T.K.; Martin-Mola, E.; McInnes, I.; Pavelka, K.; van Riel, P.; Scholte, M.; Scott, D.L.; Sokka, T.; Valesini, G.; van Vollenhoven, R.; Winthrop, K.L.; Wong, J.; Zink, A.; van der Heijde, D. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann. Rheum. Dis., 2010, 69(6), 964-975. doi: 10.1136/ard.2009.126532 PMID: 20444750
  37. da Silva, J.C.; Mariz, H.A.; da Rocha Júnior, L.F.; Santana de Oliveira, P.S.; Dantas, A.T.; Duarte, A.L.B.P.; da Rocha Pitta, I.; Galdino, S.L.; da Rocha Pitta, M.G. Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients. Clinics, 2013, 68(6), 766-771. doi: 10.6061/clinics/2013(06)07 PMID: 23778483
  38. Volin, M.V.; Harlow, L.A.; Woods, J.M.; Campbell, P.L.; Amin, M.A.; Tokuhira, M.; Koch, A.E. Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicylic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis. Arthritis Rheum., 1999, 42(9), 1927-1935. doi: 10.1002/1529-0131(199909)42:93.0.CO;2-X PMID: 10513809
  39. Fox, R.I.; Herrmann, M.L.; Frangou, C.G.; Wahl, G.M.; Morris, R.E.; Kirschbaum, B.J. How does leflunomide modulate the immune response in rheumatoid arthritis? BioDrugs, 1999, 12(4), 301-315. doi: 10.2165/00063030-199912040-00007 PMID: 18031184
  40. Gibofsky, A. Combination therapy for rheumatoid arthritis in the era of biologicals. HSS J., 2006, 2(1), 30-41. doi: 10.1007/s11420-005-0133-z PMID: 18751844
  41. Mann, D.L. Innate immunity and the failing heart: The cytokine hypothesis revisited. Circ. Res., 2015, 116(7), 1254-1268. doi: 10.1161/CIRCRESAHA.116.302317 PMID: 25814686
  42. Curtis, J.R.; Singh, J.A. Use of biologics in rheumatoid arthritis: Current and emerging paradigms of care. Clin. Ther., 2011, 33(6), 679-707. doi: 10.1016/j.clinthera.2011.05.044 PMID: 21704234
  43. Gómez-Gómez, G.J. Current stage in inflammatory bowel disease: What is next? World J. Gastroenterol., 2015, 21(40), 11282-11303. doi: 10.3748/wjg.v21.i40.11282
  44. Hodge, J.A.; Kawabata, T.T.; Krishnaswami, S.; Clark, J.D.; Telliez, J-B.; Dowty, M.E.; Menon, S.; Lamba, M.; Zwillich, S. The mechanism of action of tofacitinib: An oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Clin. Exp. Rheumatol., 2016, 34(2), 318-328. PMID: 26966791
  45. Cada, D.J.; Demaris, K.; Levien, T.L.; Baker, D.E. Tofacitinib. Hosp. Pharm., 2013, 48(5), 413-424. doi: 10.1310/hpj4805-413 PMID: 24421498
  46. Crofford, L. J. Use of NSAIDs in treating patients with arthritis. Arthritis. Res. Ther., 2013, 15(3)(3), S2. doi: 10.1186/ar4174
  47. Khalil, N.Y.; Aldosari, K.F. Meloxicam. Profiles Drug Subst. Excip. Relat. Methodol., 2020, 45, 159-197. doi: 10.1016/bs.podrm.2019.10.006 PMID: 32164967
  48. van de Laar, M.; Pergolizzi, J.V., Jr; Mellinghoff, H-U.; Merchante, I.M.; Nalamachu, S.; O’Brien, J.; Perrot, S.; Raffa, R.B. Pain treatment in arthritis-related pain: Beyond NSAIDs. Open Rheumatol. J., 2012, 6(1), 320-330. doi: 10.2174/1874312901206010320 PMID: 23264838
  49. Tanaka, Y. Corticosteroids for Treatment of Rheumatoid Arthritis. Jpn. J. Clin. Med., 2005, 63(1), 468-471.
  50. Brown, P.M.; Pratt, A.G.; Isaacs, J.D. Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers. Nat. Rev. Rheumatol., 2016, 12(12), 731-742. doi: 10.1038/nrrheum.2016.175 PMID: 27784891
  51. Kasarełło, K.; Cudnoch-Jędrzejewska, A.; Członkowski, A.; Mirowska-Guzel, D. Mechanism of action of three newly registered drugs for multiple sclerosis treatment. Pharmacol. Rep., 2017, 69(4), 702-708. doi: 10.1016/j.pharep.2017.02.017 PMID: 28550802
  52. Linares, V.; Alonso, V.; Domingo, J.L. Oxidative stress as a mechanism underlying sulfasalazine-induced toxicity. Expert Opin. Drug Saf., 2011, 10(2), 253-263. doi: 10.1517/14740338.2011.529898 PMID: 21219240
  53. Rainsford, K.D.; Parke, A.L.; Clifford-Rashotte, M.; Kean, W.F. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology, 2015, 23(5), 231-269. doi: 10.1007/s10787-015-0239-y PMID: 26246395
  54. Simon, L.S. DMARDs in the treatment of rheumatoid arthritis: Current agents and future developments. Int. J. Clin. Pract., 2000, 54(4), 243-249. doi: 10.1111/j.1742-1241.2000.tb11894.x PMID: 10912314
  55. Furst, D.E. Anakinra: Review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis. Clin. Ther., 2004, 26(12), 1960-1975. doi: 10.1016/j.clinthera.2004.12.019 PMID: 15823761
  56. Lee, E.B. A review of sarilumab for the treatment of rheumatoid arthritis. Immunotherapy, 2018, 10(1), 57-65. doi: 10.2217/imt-2017-0075 PMID: 29043871
  57. Biggioggero, M.; Crotti, C.; Becciolini, A.; Favalli, E.G. Tocilizumab in the treatment of rheumatoid arthritis: An evidence-based review and patient selection. Drug Des. Devel. Ther., 2018, 13, 57-70. doi: 10.2147/DDDT.S150580 PMID: 30587928
  58. Tanaka, Y. A review of upadacitinib in rheumatoid arthritis. Mod. Rheumatol., 2020, 30(5), 779-787. doi: 10.1080/14397595.2020.1782049 PMID: 32530345
  59. Al-Salama, Z.T.; Scott, L.J. Baricitinib: A review in rheumatoid arthritis. Drugs, 2018, 78(7), 761-772. doi: 10.1007/s40265-018-0908-4 PMID: 29687421
  60. Mohanty, S.; Panda, S.; Bhanja, A.; Pal, A.; Chandra, S.S. Novel drug delivery systems for rheumatoid arthritis: An approach to better patient compliance. Biomed. Pharmacol. J., 2019, 12(1), 157-170. doi: 10.13005/bpj/1624
  61. Higaki, M.; Ishihara, T.; Izumo, N.; Takatsu, M.; Mizushima, Y. Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate. Ann. Rheum. Dis., 2005, 64(8), 1132-1136. doi: 10.1136/ard.2004.030759 PMID: 15695536
  62. Wadhwa, R.; Paudel, K.R.; Chin, L.H.; Hon, C.M.; Madheswaran, T.; Gupta, G.; Panneerselvam, J.; Lakshmi, T.; Singh, S.K.; Gulati, M.; Dureja, H.; Hsu, A.; Mehta, M.; Anand, K.; Devkota, H.P.; Chellian, J.; Chellappan, D.K.; Hansbro, P.M.; Dua, K. Anti-Inflammatory and anticancer activities of naringenin-loaded liquid crystalline nanoparticles in vitro. J. Food Biochem., 2021, 45(1), e13572. doi: 10.1111/jfbc.13572
  63. Raffin, R.P.; Lima, A.; Lorenzoni, R.; Antonow, M.B.; Turra, C.; Alves, M.P.; Fagan, S.B. Natural lipid nanoparticles containing nimesulide: Synthesis, characterization and in vivo antiedematogenic and antinociceptive activities. J. Biomed. Nanotechnol., 2012, 8(2), 309-315. doi: 10.1166/jbn.2012.1377 PMID: 22515082
  64. Agarwal, H.; Nakara, A.; Shanmugam, V.K. Anti-inflammatory mechanism of various metal and metal oxide nanoparticles synthesized using plant extracts: A review. Biomed. Pharmacother., 2019, 109, 2561-2572. doi: 10.1016/j.biopha.2018.11.116 PMID: 30551516
  65. Khandare, J.J.; Jayant, S.; Singh, A.; Chandna, P.; Wang, Y.; Vorsa, N.; Minko, T. Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel. Bioconjug. Chem., 2006, 17(6), 1464-1472. doi: 10.1021/bc060240p PMID: 17105225
  66. Türker, S. Erdoğan, S.; Özer, Y.A.; Bilgili, H.; Deveci, S. Enhanced efficacy of diclofenac sodium-loaded lipogelosome formulation in intra-articular treatment of rheumatoid arthritis. J. Drug Target., 2008, 16(1), 51-57. doi: 10.1080/10611860701725191 PMID: 18172820
  67. Jeengar, M.K.; Rompicharla, S.V.K.; Shrivastava, S.; Chella, N.; Shastri, N.R.; Naidu, V.G.M.; Sistla, R. Emu oil based nano-emulgel for topical delivery of curcumin. Int. J. Pharm., 2016, 506(1-2), 222-236. doi: 10.1016/j.ijpharm.2016.04.052 PMID: 27109049
  68. Khichariya, A.; Jeswani, G.; Choudhary, R.; Alexander, A.; Nakhate, K.T.; Ramchandra Badwaik, H. Formulation of plumbagin-loaded microemulsion: Evaluation of anti-rheumatoid efficacy in Wistar rat model. J. Mol. Liq., 2022, 363, 119851. doi: 10.1016/j.molliq.2022.119851
  69. Koo, O.M.Y.; Rubinstein, I.; Önyüksel, H. Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis. Pharm. Res., 2011, 28(4), 776-787. doi: 10.1007/s11095-010-0330-4 PMID: 21132352
  70. Kapoor, B.; Singh, S.K.; Gulati, M.; Gupta, R.; Vaidya, Y. Application of liposomes in treatment of rheumatoid arthritis: Quo vadis. ScientificWorldJournal, 2014, 2014, 1-17. doi: 10.1155/2014/978351 PMID: 24688450
  71. Ghorani, V.; Marefati, N.; Shakeri, F.; Rezaee, R.; Boskabady, M.; Boskabady, M.H. The effects of Allium cepa extract on tracheal responsiveness, lung inflammatory cells and phospholipase A2 level in asthmatic rats. Iran. J. Allergy Asthma Immunol., 2018, 17(3), 221-231. PMID: 29908539
  72. Arulmozhi, S.; Mazumder, P.M.; Sathiyanarayanan, L.; Ashok, P. Anti-arthritic and antioxidant activity of leaves of Alstonia scholaris Linn. R.Br. Eur. J. Integr. Med., 2011, 3(2), e83-e90. doi: 10.1016/j.eujim.2011.04.019
  73. Liu, J.; Wang, Z.T.; Ji, L.L.; Ge, B.X. Inhibitory effects of neoandrographolide on nitric oxide and prostaglandin E2 production in LPS-stimulated murine macrophage. Mol. Cell. Biochem., 2007, 298(1-2), 49-57. doi: 10.1007/s11010-006-9349-6 PMID: 17109078
  74. Magdalou, J.; Chen, L.; Wang, H.; Qin, J.; Wen, Y.; Li, X.; Shang, L.; Li, J. Angelica sinensis and osteoarthritis: A natural therapeutic link? Biomed. Mater. Eng., 2015, 25(s1)(Suppl.), 179-186. doi: 10.3233/BME-141250 PMID: 25538068
  75. Nadkarni, K.M. Indian Materia Medica; Popular Pakashan Pvt. Ltd: Bombay, India, 2009, pp. 320-325.
  76. Kast, R.E. Borage oil reduction of rheumatoid arthritis activity may be mediated by increased cAMP that suppresses tumor necrosis factor-alpha. Int. Immunopharmacol., 2001, 1(12), 2197-2199. doi: 10.1016/S1567-5769(01)00146-1 PMID: 11710548
  77. Umar, S.; Umar, K.; Sarwar, A.H.M.G.; Khan, A.; Ahmad, N.; Ahmad, S.; Katiyar, C.K.; Husain, S.A.; Khan, H.A. Boswellia serrata extract attenuates inflammatory mediators and oxidative stress in collagen induced arthritis. Phytomedicine, 2014, 21(6), 847-856. doi: 10.1016/j.phymed.2014.02.001 PMID: 24667331
  78. Mueller, M.; Weinmann, D.; Toegel, S.; Holzer, W.; Unger, F.M.; Viernstein, H. Compounds from Caesalpinia sappan with anti-inflammatory properties in macrophages and chondrocytes. Food Funct., 2016, 7(3), 1671-1679. doi: 10.1039/C5FO01256B PMID: 26951869
  79. Tanwar, A.; Chawla, R.; Ansari, M.M. Neha; Thakur, P.; Chakotiya, A.S.; Goel, R.; Ojha, H.; Asif, M.; Basu, M.; Arora, R.; Khan, H.A. In vivo anti-arthritic efficacy of Camellia sinensis (L.) in collagen induced arthritis model. Biomed. Pharmacother., 2017, 87, 92-101. doi: 10.1016/j.biopha.2016.12.089 PMID: 28049097
  80. Feng, X.; Lu, J.; Xin, H.; Zhang, L.; Wang, Y.; Tang, K. Anti-arthritic active fraction of Capparis spinosa L. fruits and its chemical constituents. Yakugaku Zasshi, 2011, 131(3), 423-429. doi: 10.1248/yakushi.131.423 PMID: 21372539
  81. Chippada, S.; Volluri, S.; Bammidi, S.; Vangalapati, M. in vitro anti-arthritic activity of methanolic extract of Centella asiatica. Biosci. Biotechnol. Res. Asia, 2011, 8(1), 337-340. doi: 10.13005/bbra/868
  82. Vetal, S.; Bodhankar, S.L.; Mohan, V.; Thakurdesai, P.A. Anti-inflammatory and anti-arthritic activity of type-A procyanidine polyphenols from bark of Cinnamomum zeylanicum in rats. Food Sci. Hum. Wellness, 2013, 2(2), 59-67. doi: 10.1016/j.fshw.2013.03.003
  83. Narendhirakannan, R.T.; Kandaswamy, M.; Subramanian, S. Anti-inflammatory activity of Cleome gynandra L. on hematological and cellular constituents in adjuvant-induced arthritic rats. J. Med. Food, 2005, 8(1), 93-99. doi: 10.1089/jmf.2005.8.93 PMID: 15857216
  84. Ragavi, R.; Surendran, S.A. Commiphora mukul: An overview. Res. J. Pharm. Technol., 2018, 11(7), 3205-3208. doi: 10.5958/0974-360X.2018.00589.9
  85. Rajeshwari, C.U.; Siri, S.; Andallu, B. Antioxidant and antiarthritic potential of coriander (Coriandrum sativum L.) leaves. ESPEN J., 2012, 7(6), e223-e228. doi: 10.1016/j.clnme.2012.09.005
  86. Mathai, N.J.; Sony, D.; Mane, P.P.; Shetty, C.B.; Latheef, L.; Kamath, K.; Khaleed, M.; Kochikuzhyil, B.M.; Baliga, M.S. Antiarthritic effects of turmeric and curcumin: A revisit. In: Polyphenols: Prevention and Treatment of Human Disease; Academic Press, 2018; pp. 247-252. doi: 10.1016/B978-0-12-813008-7.00020-5
  87. Mishra, N.K.; Bstia, S.; Mishra, G.; Chowdary, A.K.; Patra, S. Anti-arthritic activity of Glycyrrhiza glabra, Boswellia serrata and their synergistic activity in combined formulation studied in freund’s adjuvant induced arthritic rats. J. Pharm. Educ. Res, 2011, 2, 92-98.
  88. Mehta, A.; Sethiya, N.K.; Mehta, C.; Shah, G.B. Anti–arthritis activity of roots of Hemidesmus indicus R.Br. (Anantmul) in rats. Asian Pac. J. Trop. Med., 2012, 5(2), 130-135. doi: 10.1016/S1995-7645(12)60011-X PMID: 22221757
  89. Gundamaraju, R.; Sheeba, D.S.; Ramesh, C. Evaluation of anti-arthritic effects of Lantana camara var Linn. using acute model on albino rats. Int. J. Adv. Pharm. Sci., 2012, 3, 272-277.
  90. Nadkarni, K.M. Indian Materia Medica; Poupular Pakashan Pvt. Ltd: Bombay, India, 2009, pp. 180-186.
  91. Kripa, K.G.; Chamundeeswari, D.; Thanka, J.; Uma Maheswara Reddy, C. Modulation of inflammatory markers by the ethanolic extract of Leucas aspera in adjuvant arthritis. J. Ethnopharmacol., 2011, 134(3), 1024-1027. doi: 10.1016/j.jep.2011.01.010 PMID: 21251972
  92. Chen, W.C.; Liou, S.S.; Tzeng, T.F.; Lee, S.L.; Liu, I.M. Wound repair and anti-inflammatory potential of Lonicera japonica in excision wound-induced rats. BMC Complement. Altern. Med., 2012, 12(1), 226. doi: 10.1186/1472-6882-12-226 PMID: 23173654
  93. Aggarwal, A.; Mali, R.R. Ocimum tenuiflorum: A medicinal plants with its versatile uses. Int. J. Rec. Adv. Sci. Technol., 2015, 2(2), 1-10. doi: 10.30750/ijrast.221
  94. Mali, S.M.; Sinnathambi, A.; Kapase, C.U.; Bodhankar, S.L.; Mahadik, K.R. Anti-arthritic activity of standardised extract of Phyllanthus amarus in Freund’s complete adjuvant induced arthritis. Biomed. Aging Pathol., 2011, 1(3), 185-190. doi: 10.1016/j.biomag.2011.09.004
  95. Yende, S.; Sannapuri, V.; Vyawahare, S.UN. H. Antirheumatoid activity of aqueous extract of Piper longum on freund’s adjuvant-induced arthritis in rats. Int. J. Pharm. Sci. Res., 2010, 1(9), 129-133. doi: 10.13040/ijpsr.0975-82321(9-s)
  96. Gautam, R.K.; Sharma, S.; Sharma, K.; Gupta, G. Evaluation of antiarthritic activity of butanol fraction of Punica granatum Linn. rind extract against freund’s complete adjuvant-induced arthritis in rats. J. Environ. Pathol. Toxicol. Oncol., 2018, 37(1), 53-62. doi: 10.1615/JEnvironPatholToxicolOncol.2018025137 PMID: 29773000
  97. Hussain, A.; Aslam, B.; Muhammad, F.; Faisal, M.N.; Kousar, S.; Mushtaq, A.; Bari, M.U. Anti-arthritic activity of Ricinus communis L. and Withania somnifera L. extracts in adjuvant-induced arthritic rats via modulating inflammatory mediators and subsiding oxidative stress. Iran. J. Basic Med. Sci., 2021, 24(7), 951-961. doi: 10.22038/ijbms.2021.55145.12355 PMID: 34712426
  98. Gokhale, A.B.; Damre, A.S.; Kulkarni, K.R.; Saraf, M.N. Preliminary evaluation of anti-inflammatory and anti-arthritic activity of S. lappa, A. speciosa and A. aspera. Phytomedicine, 2002, 9(5), 433-437. doi: 10.1078/09447110260571689 PMID: 12222664
  99. Ramprasath, V.R.; Shanthi, P.; Sachdanandam, P. Anti-inflammatory effect of Semecarpus anacardium Linn. Nut extract in acute and chronic inflammatory conditions. Biol. Pharm. Bull., 2004, 27(12), 2028-2031. doi: 10.1248/bpb.27.2028 PMID: 15577226
  100. Gupta, S.R.; Nirmal, S.A.; Patil, R.Y.; Asane, G.S. Anti-arthritic activity of various extracts of Sida rhombifolia aerial parts. Nat. Prod. Res., 2009, 23(8), 689-695. doi: 10.1080/14786410802242778 PMID: 19418351
  101. Devi, K.P. Milk Thistle (Silybum marianum) Nonvitamin and Nonmineral Nutritional Supplements; Elsevier, Academic Press, 2019, p. 321-325.
  102. Lim, D.; Lee, E.; Jeong, E.; Jang, Y.P.; Kim, J. Stemona tuberosa prevented inflammation by suppressing the recruitment and the activation of macrophages in vivo and in vitro. J. Ethnopharmacol., 2015, 160, 41-51. doi: 10.1016/j.jep.2014.11.032 PMID: 25476485
  103. Ekambaram, S.; Perumal, S.S.; Subramanian, V. Evaluation of antiarthritic activity of Strychnos potatorum Linn seeds in Freund’s adjuvant induced arthritic rat model. BMC Complement. Altern. Med., 2010, 10(1), 56. doi: 10.1186/1472-6882-10-56 PMID: 20939932
  104. Nair, V.; Singh, S.; Gupta, Y.K. Anti-arthritic and disease modifying activity of Terminalia chebula Retz. in experimental models. J. Pharm. Pharmacol., 2010, 62(12), 1801-1806. doi: 10.1111/j.2042-7158.2010.01193.x PMID: 21054408
  105. Chhatre, S.; Nesari, T.; Kanchan, D.; Somani, G.; Sathaye, S. Phytopharmacological overview of Tribulus terrestris. Pharmacogn. Rev., 2014, 8(15), 45-51. doi: 10.4103/0973-7847.125530 PMID: 24600195
  106. G, S.; G L, S.; Pushpan, C.K.; Nambisan, B.; A, H. Evaluation of anti-arthritic potential of Trigonella foenum graecum L. (Fenugreek) mucilage against rheumatoid arthritis. Prostaglandins Other Lipid Mediat., 2018, 138, 48-53. doi: 10.1016/j.prostaglandins.2018.08.002 PMID: 30107253
  107. Li, H.; Hu, R.; Xu, S.; Dai, Z.; Wu, X.; Hu, J.; Liao, X. Tripterygium wilfordii Hook. Evid. Based Complement. Alternat. Med., 2022, 2022, 3151936. doi: 10.1155/2022/3151936
  108. Xie, T.Z.; Zhao, Y.L.; Wang, H.; Chen, Y.C.; Wei, X.; Wang, Z.J.; He, Y.J.; Zhao, L.X.; Luo, X.D. New steroidal alkaloids with anti-inflammatory and analgesic effects from Veratrum grandiflorum. J. Ethnopharmacol., 2022, 293, 115290. doi: 10.1016/j.jep.2022.115290 PMID: 35452774
  109. Gill, B.S.; Mehra, R. Navgeet; Kumar, S. Vitex negundo and its medicinal value. Mol. Biol. Rep., 2018, 45(6), 2925-2934. doi: 10.1007/s11033-018-4421-3 PMID: 30311123
  110. Khan, M.A.; Subramaneyaan, M.; Arora, V.K.; Banerjee, B.D.; Ahmed, R.S. Effect of Withania somnifera (Ashwagandha) root extract on amelioration of oxidative stress and autoantibodies production in collagen-induced arthritic rats. J. Complement. Integr. Med., 2015, 12(2), 117-125. doi: 10.1515/jcim-2014-0075 PMID: 25803089
  111. Lin, B.; Zhao, Y.; Han, P.; Yue, W.; Ma, X.Q.; Rahman, K.; Zheng, C.J.; Qin, L.P.; Han, T. Anti-arthritic activity of Xanthium strumarium L. extract on complete Freund׳s adjuvant induced arthritis in rats. J. Ethnopharmacol., 2014, 155(1), 248-255. doi: 10.1016/j.jep.2014.05.023 PMID: 24862493
  112. Cheeke, P.R.; Piacente, S.; Oleszek, W. Anti-inflammatory and anti-arthritic effects of yucca schidigera: A review. J. Inflamm., 2006, 3(1), 6. doi: 10.1186/1476-9255-3-6 PMID: 16571135
  113. Kamboj, A.; Saluja, A. Phytopharmacological review of Xanthium strumarium L. (Cocklebur). Int. J. Gre. Pharm., 2010, 4(3), 129-139. doi: 10.4103/0973-8258.69154
  114. Khan, Y.; Shah, S.; Ullah, S. Ethnomedicinal, pharmacological and phytochemical evaluation of Xanthium strumarium L. Int. J. Sci. Res. Sci. Eng. Technol., 2020, 11(7), 587-595.
  115. Patil, M.V.K.; Kandhare, A.D.; Bhise, S.D. Anti-arthritic and anti-inflammatory activity of Xanthium srtumarium L. ethanolic extract in Freund’s complete adjuvant induced arthritis. Biomed. Aging Pathol., 2012, 2(1), 6-15. doi: 10.1016/j.biomag.2012.01.002
  116. Jinous, A. Phytochemistry and pharmacological properties of Ruta graveolens L. J. Med. Plants Res., 2012, 6(23), 3942-3949. doi: 10.5897/JMPR12.040
  117. Colucci-D’Amato, L.; Cimaglia, G. Ruta graveolens as a potential source of neuroactive compounds to promote and restore neural functions. J. Tradit. Complement. Med., 2020, 10(3), 309-314. doi: 10.1016/j.jtcme.2020.05.002 PMID: 32670826
  118. Vinegar, R.; Schreiber, W.; Hugo, R. Biphasic development of carrageenin edema in rats. J. Pharmacol. Exp. Ther., 1969, 166(1), 96-103. PMID: 5776026
  119. Ratheesh, M. Anti-Inflammatory activity of Ruta graveolens Linn on carrageenan induced paw edema in wistar male rats. Afr. J. Biotechnol., 2007, 6(10), 1209-1211.
  120. Endale, M.; Lee, W.M.; Kwak, Y.S.; Kim, N.M.; Kim, B.K.; Kim, S.H.; Cho, J.; Kim, S.; Park, S.C.; Yun, B.S.; Ko, D.; Rhee, M. Torilin ameliorates type II collagen-induced arthritis in mouse model of rheumatoid arthritis. Int. Immunopharmacol., 2013, 16(2), 232-242. doi: 10.1016/j.intimp.2013.04.012 PMID: 23623942
  121. Chowdhury, A.K.; Steinberger, E. Effect of 5alpha reduced androgens on sex accessory organs, initiation and maintenance of spermatogenesis in the rat. Biol. Reprod., 1975, 12(5), 609-617. doi: 10.1095/biolreprod12.5.609 PMID: 1220829
  122. Khouri, N.A.; El-Akawi, Z. Antiandrogenic activity of Ruta graveolens L in male Albino rats with emphasis on sexual and aggressive behavior. Neuroendocrinol. Lett., 2005, 26(6), 823-829. PMID: 16380694
  123. Mahmoud, A. Antihyperglycemic, antihyperlipidemic and antioxidant effects and the probable mechanisms of action of Ruta graveolens infusion and rutin in nicotinamide. Diabetologia, 2010, 39, 15-35.
  124. Liao, K.; Yin, M. Individual and combined antioxidant effects of seven phenolic agents in human erythrocyte membrane ghosts and phosphatidylcholine liposome systems: Importance of the partition coefficient. J. Agric. Food Chem., 2000, 48(6), 2266-2270. doi: 10.1021/jf990946w PMID: 10888534
  125. Raz, I.; Eldor, R.; Cernea, S.; Shafrir, E. Diabetes: Insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes Metab. Res. Rev., 2005, 21(1), 3-14. doi: 10.1002/dmrr.493 PMID: 15386813
  126. Pathak, S.; Multani, A.; Banerji, P.; Banerji, P. Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: A novel treatment for human brain cancer. Int. J. Oncol., 2003, 23(4), 975-982. doi: 10.3892/ijo.23.4.975 PMID: 12963976
  127. Ratheesh, M.; Shyni, G.L.; Sindhu, G.; Helen, A. Protective effects of isolated polyphenolic and alkaloid fractions of Ruta graveolens L. on acute and chronic models of inflammation. Inflammation, 2010, 33(1), 18-24. doi: 10.1007/s10753-009-9154-y PMID: 19777330
  128. Negi, S.; Bisht, V.K.; Bhandari, A.K.; Bhatt, V.P.; Sati, M.K.; Mohanty, J.P.; Sundriyal, R.C. Antidiarrheal activity of methanol extract and major essential oil contents of Saussurea lappa Clarke. Afr. J. Pharm. Pharmacol., 2013, 7(8), 474-477. doi: 10.5897/AJPP2012.1532
  129. Mitra, S.K.; Gopumadhavan, S.; Hemavathi, T.S.; Muralidhar, T.S.; Venkataranganna, M.V. Protective effect of UL-409, a herbal formulation against physical and chemical factor induced gastric and duodenal ulcers in experimental animals. J. Ethnopharmacol., 1996, 52(3), 165-169. doi: 10.1016/0378-8741(95)01414-4 PMID: 8771458
  130. Sutar, N.; Garai, R.; Sharma, U.S.; Singh, N.; Roy, S.D. Antiulcerogenic activity of Saussurea lappa root. Int. J. Pharm. Life Sci., 2011, 2, 516-520.
  131. Hasson, S.S.A.; Al-Balushi, M.S. KhazinaAlharthy; Al-Busaidi, J.; MunaSulimanAldaihani; Othman, M.S.; Said, E.A.; Habal, O.; Sallam, T.A.; Aljabri, A.A.; AhmedIdris, M. Evaluation of anti–resistant activity of Auklandia(Saussurea lappa) root against some human pathogens. Asian Pac. J. Trop. Biomed., 2013, 3(7), 557-562. doi: 10.1016/S2221-1691(13)60113-6 PMID: 23836413
  132. Robinson, A.; Kumar, T.V.; Sreedhar, E.; Naidu, V.G.M.; Krishna, S.R.; Babu, K.S.; Srinivas, P.V.; Rao, J.M. A new sesquiterpene lactone from the roots of Saussurea lappa: Structure–anticancer activity study. Bioorg. Med. Chem. Lett., 2008, 18(14), 4015-4017. doi: 10.1016/j.bmcl.2008.06.008 PMID: 18579374
  133. Yaeesh, S.; Jamal, Q.; Shah, A.J.; Gilani, A.H. Antihepatotoxic activity of Saussurea lappa extract on D-galactosamine and lipopolysaccharide-induced hepatitis in mice. Phytother. Res., 2010, 24(S2)(2), S229-S232. doi: 10.1002/ptr.3089 PMID: 20041433
  134. Chen, H.C.; Chou, C.K.; Lee, S.D.; Wang, J.C.; Yeh, S.F. Active compounds from Saussurea lappa Clarks that suppress hepatitis B virus surface antigen gene expression in human hepatoma cells. Antiviral Res., 1995, 27(1-2), 99-109. doi: 10.1016/0166-3542(94)00083-K PMID: 7486962
  135. Webster, G.L. Classification of the Euphorbiaceae. Ann. Mo. Bot. Gard., 1994, 81(1), 3-32. doi: 10.2307/2399908
  136. Yang, Y.; Chen, X.; Luan, F.; Wang, M.; Wang, Z.; Wang, J.; He, X. Euphorbia helioscopia L.: A phytochemical and pharmacological overview. Phytochemistry, 2021, 184, 112649. doi: 10.1016/j.phytochem.2020.112649 PMID: 33440297
  137. Kinghorn, A.D.; Evans, F.J. A biological screen of selected species of the genus Euphorbia for skin irritant effects. Planta Med., 1975, 28(4), 326-335. PMID: 1208681
  138. Ur, M.; Khattak, R.; Farhat, A.; Khan, M.; Ur, R.; Khattak, S.; Muhammad, M. Screening of crude phytochemicals and antimicrobial activities of selected medicinal plants of Peshawar region Khyber Pakhtoon Khawa Pakistan. Middle East J. Sci. Res., 2011, 9(2), 200-208.
  139. Wu, T.S.; Lin, Y.M.; Haruna, M.; Pan, D.J.; Shingu, T.; Chen, Y.; Hsu, H.Y.; Nakano, T.; Lee, K.H. Antitumor agents, 119. Kansuiphorins A and B, two novel antileukemic diterpene esters from Euphorbia kansui. J. Nat. Prod., 1991, 54(3), 823-829. doi: 10.1021/np50075a011 PMID: 1955882
  140. Nazir, M.; Ahmad, W.; Kreiser, W. Isolation and NMR-assignments of 19αH-Lupeol from E. helioscopia Linn (N.O. Euphorbiaceae). Pak. J. Sci. Ind. Res., 1998, 41, 6-10.
  141. Tao, H.W.; Hao, X.J.; Liu, P.P.; Zhu, W.M. Cytotoxic macrocyclic diterpenoids from Euphorbia helioscopia. Arch. Pharm. Res., 2008, 31(12), 1547-1551. doi: 10.1007/s12272-001-2149-3 PMID: 19099222
  142. Kawase, A.; Kutani, N. Some properties of a new flavonoid, Tithymalin, isolated from the herbs of Euphorbia helioscopia Linnaeous. Agric. Biol. Chem., 1968, 32(1), 121-122. doi: 10.1080/00021369.1968.10859027
  143. Ghen, Y.; Tang, Z.J.; Jiang, F.X.; Zhang, X.X.; Lao, A.N. Studies on the active principles of Ze-Qi (Euphorbia helioscopia L.), a drug used for chronic bronchitis (I) (author’s transl). Yao Xue Xue Bao, 1979, 14(2), 91-95. PMID: 506714
  144. Lee, S.H.; Tanaka, T.; Nonaka, G.; Nishioka, I. Tannins and related compounds. XCV. Isolation and characterization of helioscopinins and helioscopins, four new hydrolyzable tannins from Euphorbia helioscopia L. (1). Chem. Pharm. Bull., 1990, 38(6), 1518-1523. doi: 10.1248/cpb.38.1518
  145. Zhang, W.; Guo, Y.W. Chemical studies on the constituents of the chinese medicinal herb Euphorbia helioscopia L. Chem. Pharm. Bull., 2006, 54(7), 1037-1039. doi: 10.1248/cpb.54.1037 PMID: 16819227
  146. Singh, A.; Chibber, P.; Kolimi, P.; Malik, T.A.; Kapoor, N.; Kumar, A.; Kumar, N.; Gandhi, S.G.; Singh, S.; Abdullah, S.T.; Vishwakarma, R.; Singh, G. Rohitukine inhibits NF-κB activation induced by LPS and other inflammatory agents. Int. Immunopharmacol., 2019, 69, 34-49. doi: 10.1016/j.intimp.2019.01.015 PMID: 30665042
  147. Kong, K.W.; Mat Junit, S.; Aminudin, N.; Abdul Aziz, A. Phytochemicals in Barringtonia species: Linking their traditional uses as food and medicine with current research. J. Herb. Med., 2020, 19, 100299. doi: 10.1016/j.hermed.2019.100299
  148. Gowri, P.M.; Tiwari, A.K.; Ali, A.Z.; Rao, J.M. Inhibition of α-glucosidase and amylase by bartogenic acid isolated from Barringtonia racemosa Roxb. seeds. Phytother. Res., 2007, 21(8), 796-799. doi: 10.1002/ptr.2176 PMID: 17533638
  149. Behbahani, M.; Tiwari, A.K.; Ali, A.M.; Muse, R.; Mohd, N.B. Anti-oxidant and anti-inflammatory activities of leaves of Barringtonia racemosa. J. Med. Plants Res., 2007, 1(5), 95-102. doi: 10.5897/JMPR.9000106
  150. Nielen, M.M.J.; van Schaardenburg, D.; Reesink, H.W.; Twisk, J.W.R.; van de Stadt, R.J.; van der Horst-Bruinsma, I.E.; de Koning, M.H.M.T.; Habibuw, M.R.; Dijkmans, B.A.C. Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis. Ann. Rheum. Dis., 2006, 65(4), 535-537. doi: 10.1136/ard.2005.040659 PMID: 16079166
  151. Yeh, E.T.H. CRP as a mediator of disease. Circulation, 2004, 109(21 Suppl. 1), II11-4. doi: 10.1161/01.CIR.0000129507.12719.80
  152. Dianita, R.; Jantan, I. Ethnomedicinal uses, phytochemistry and pharmacological aspects of the genus Premna: A review. Pharm. Biol., 2017, 55(1), 1715-1739. doi: 10.1080/13880209.2017.1323225 PMID: 28486830
  153. Rajendran, R. L, S.; R, M.S.; N, S.B. Cardiac stimulant activity of bark and wood of Premna serratifolia. Bangladesh J. Pharmacol., 2008, 3(2), 107-113. doi: 10.3329/bjp.v3i2.952
  154. Gopal, R.H.; Purushothaman, K.K. Effect of plant isolates on coagulation of blood: An in-vitro study. Bull. Med. Ethnobot. Res., 1984, 5, 171-177.
  155. Rathore, R.S.; Prakash, A.; Singh, P.P. Premna integre-folia Linn, a preliminary study of anti-inflammatory activity. Rheumatism, 1977, 12, 130-134.
  156. Dash, G.K.; Patrolm, C.P.; Maiti, A.K. A study on the anti-hyperglycaemic effect of roots of Premna corymbosa Rottl. J. Nat. Rem., 2005, 5, 31-34.
  157. Desrivot, J.; Waikedre, J.; Cabalion, P.; Herrenknecht, C.; Bories, C.; Hocquemiller, R.; Fournet, A. Antiparasitic activity of some new caledonian medicinal plants. J. Ethnopharmacol., 2007, 112(1), 7-12. doi: 10.1016/j.jep.2007.01.026 PMID: 17329051
  158. Basha, N.S. Evaluation of in vitro antioxidant activity of stem-bark and wood of Premna serratifolia Linn., (Verbenaceae). Phytochemistry, 2009, 1(1), 11-14. PMID: 19147161
  159. Choi, E.J.; Bae, S.C.; Yu, R.; Youn, J.; Sung, M.K. Dietary vitamin E and quercetin modulate inflammatory responses of collagen-induced arthritis in mice. J. Med. Food, 2009, 12(4), 770-775. doi: 10.1089/jmf.2008.1246 PMID: 19735175
  160. Kavitha, K.; Sangeetha, K.; Sridevi, K.S.; Sujatha, K.; Umamaheswari, S. Phytochemical and pharmacological profile of Justicia gendarussa Burm f. – review. J. Pharm. Res., 2014, 8(7), 990-997.
  161. Sastri, B.N. Wealth of India: Raw materials; Council of Scientific and Industrial Research: New Delhi, 1959, 5, p. 312-333.
  162. Jayasinghe, D.M. Ayurveda Pharmacopeia; Department Ayurveda: Colombo, Sri Lanka, 1979, pp. 30-42.
  163. Wahi, S.P.; Wahi, A.K.; Kapoor, R. Chemical study of the leaf of Justicia gendarussa Burm. JRIM, 1974, 9, 65-76.
  164. Sawatzky, D.A.; Willoughby, D.A.; Colville-Nash, P.R.; Rossi, A.G. The involvement of the apoptosis-modulating proteins ERK 1/2, Bcl-xL and Bax in the resolution of acute inflammation in vivo. Am. J. Pathol., 2006, 168(1), 33-41. doi: 10.2353/ajpath.2006.050058 PMID: 16400007
  165. Subbaraju, G.V.; Sridhar, C.; Krishnaraju, A.V. Antiinflammatory constituents of teramnus labialis. Indian J. Pharm. Sci., 2006, 68(1), 111-114. doi: 10.4103/0250-474X.22981
  166. Varma, R.S.; Ashok, G.; Vidyashankar, S.; Patki, P.; Nandakumar, K.S. Ethanol extract of Justicia gendarussa inhibits lipopolysaccharide stimulated nitric oxide and matrix metalloproteinase-9 expression in murine macrophage. Pharm. Biol., 2011, 49(6), 648-652. doi: 10.3109/13880209.2010.527993 PMID: 21554007
  167. The Wealth of India: A Dictionary of Indian Raw Materials & Industrial Products; Council of Scientific & Industrial Research: New Delhi, India, 1992, 10, p. 19-21.
  168. Kritikar, K.R.; Basu, B.D. Indian Medicinal Plants, 1975, 3, 672-675.
  169. Tandon, S.; Rastogi, R. Studies on the chemical constituents of Spondias pinnata. Planta Med., 1976, 29(2), 190-192. doi: 10.1055/s-0028-1097651 PMID: 948520
  170. Rastogi, R.P.; Mehrotra, B.N. Compendium of Indian Medicinal Plant; CDRI, Lucknow & National Institute of Science communication: New Delhi, India, 1979, vol I and II, p. 379 & 643.
  171. Valsaraj, R.; Pushpangadan, P.; Smitt, U.W.; Adsersen, A.; Nyman, U. Antimicrobial screening of selected medicinal plants from India. J. Ethnopharmacol., 1997, 58(2), 75-83. doi: 10.1016/S0378-8741(97)00085-8 PMID: 9406894
  172. Verpoorte, R.; Siwon, J.; Tieken, M.E.M.; Svendsen, A.B. Studies on indonesian medicinal plants. V. the alkaloids of Anamirta cocculus. J. Nat. Prod., 1981, 44(2), 221-224. doi: 10.1021/np50014a013
  173. Darabpour, E.; Poshtkouhian Bavi, A.; Motamedi, H.; Seyyed Nejad, S.M. Antibacterial activity of different parts of Peganum harmala L. growing in Iran against multi-drug resistant bacteria. Excli J., 2011, 10, 252-263. PMID: 29033706
  174. Shahrajabian, M.H.; Sun, W.; Cheng, Q. Improving health benefits with considering traditional and modern health benefits of Peganum harmala. Clinical Phytoscience, 2021, 7(1), 18. doi: 10.1186/s40816-021-00255-7
  175. Li, S.; Cheng, X.; Wang, C. A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum. J. Ethnopharmacol., 2017, 203, 127-162. doi: 10.1016/j.jep.2017.03.049 PMID: 28359849
  176. Asgarpanah, J.; Ramezanloo, F. Chemistry, pharmacology and medicinal properties of Peganum harmala L. Afr. J. Pharm. Pharmacol., 2012, 6(22), 573-1580. doi: 10.5897/AJPP11.876
  177. Khan, N.A.; Raina, A.; Wagay, N.A.; Tantray, Y.R. Distribution, status, pharmacological, and traditional importance of Peganum harmala L. Int. J. Adv. Res. Sci. Eng., 2017, 6(8), 1887-1893.
  178. Saadabi, A.M.A. Antifungal activity of some Saudi plants used in traditional medicine. Asian J. Plant Sci., 2006, 5(5), 907-909. doi: 10.3923/ajps.2006.907.909
  179. Moloudizargari, M.; Mikaili, P.; Aghajanshakeri, S.; Asghari, M.; Shayegh, J. Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids. Pharmacogn. Rev., 2013, 7(14), 199-212. doi: 10.4103/0973-7847.120524 PMID: 24347928
  180. Herraiz, T. González, D.; Ancín-Azpilicueta, C.; Arán, V.J.; Guillén, H. β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food Chem. Toxicol., 2010, 48(3), 839-845. doi: 10.1016/j.fct.2009.12.019 PMID: 20036304
  181. Akhtar, M.F.; Raza, S.A.; Saleem, A.; Hamid, I.; Ashraf Baig, M.M.F.; Sharif, A.; Sohail, K.; Javaid, Z.; Saleem, U.; Rasul, A. Appraisal of anti-arthritic and anti-inflammatory potential of folkloric medicinal plant Peganum harmala. Endocr. Metab. Immune Disord. Drug Targets, 2022, 22(1), 49-63. doi: 10.2174/1871530321666210208211310 PMID: 33563161
  182. Kamble, V.R.; Sayed, B.K.; Qureshi, N. Screening of CSDPs for AM fungal association from Arnala and Kalamb beach Maharashtra. IOSR J. Pharm. Biol. Sci., 2012, 2(4), 44-47. doi: 10.9790/3008-0244447
  183. Khare, C.P. Indian Medicinal Plants: An Illustrated Dictionary; Springer-Verlag Heidelberg: New York, 2007, pp. 399-400. doi: 10.1007/978-0-387-70638-2
  184. Lodhi, S.; Jain, A.P.; Sharma, V.K.; Singhai, A.K. Wound-healing effect of flavonoid-rich fraction from Tephrosia purpurea Linn. on streptozotocin-induced diabetic rats. J. Herbs Spices Med. Plants, 2013, 19(2), 191-205. doi: 10.1080/10496475.2013.779620
  185. Rastogi, R.P.; Melhotra, B.N. Compendium of Indian Medicinal Plants; Central Drug Research Institute: Lucknow, 1993, Vol. II, p. 446.
  186. Mali, P.C.; Ansari, A.S.; Chaturvedi, M. Antifertility effect of chronically administered Martynia annua root extract on male rats. J. Ethnopharmacol., 2002, 82(2-3), 61-67. doi: 10.1016/S0378-8741(02)00084-3 PMID: 12241978
  187. Chatpalliwar, V.A.; Joharapurkar, A.A.; Wanjari, M.M.; Chakraborty, R.R.; Kharkar, V.T. Anti-inflammatory activity of Martynia diandra GLOX. Indian Drugs, 2002, 39, 543-545.
  188. Kaushik, S.; Jain, P.; Satapathy, T.; Purabiya, P.; Roy, A. Evaluation of anti-arthritic and anti-inflammatory activities of Martynia annua L. Ethanolic extract. Clinical Phytoscience, 2021, 7(1), 7. doi: 10.1186/s40816-021-00250-y
  189. Mukhlesur Rahman, M.; Gibbons, S.; Gray, A.I. Isoflavanones from Uraria picta and their antimicrobial activity. Phytochemistry, 2007, 68(12), 1692-1697. doi: 10.1016/j.phytochem.2007.04.015 PMID: 17540419
  190. Patel, J.J.; Acharya, S.R.; Acharya, N.S. Clerodendrum serratum (L.) Moon. – A review on traditional uses, phytochemistry and pharmacological activities. J. Ethnopharmacol., 2014, 154(2), 268-285. doi: 10.1016/j.jep.2014.03.071 PMID: 24727551
  191. Hazekamp, A.; Verpoorte, R.; Panthong, A. Isolation of a bronchodilator flavonoid from the Thai medicinal plant Clerodendrum petasites. J. Ethnopharmacol., 2001, 78(1), 45-49. doi: 10.1016/S0378-8741(01)00320-8 PMID: 11585687
  192. Steane, D.A.; Scotland, R.W.; Mabberley, D.J.; Olmstead, R.G. Molecular systematics of Clerodendrum (Lamiaceae): ITS sequences and total evidence. Am. J. Bot., 1999, 86(1), 98-107. doi: 10.2307/2656958 PMID: 21680349
  193. Babenko, N.A.; Shakhova, E.G. Effects of flavonoids on sphingolipid turnover in the toxin-damaged liver and liver cells. Lipids Health Dis., 2008, 7(1), 1-11. doi: 10.1186/1476-511X-7-1 PMID: 18226198
  194. Tiwari, R.K.; Chanda, S.M.U.; Singh, M,; Agarwal, S. Anti-inflammatory and anti-arthritic potential of standardized extract of Clerodendrum serratum (L.) moon. Front. Pharmacol., 2021, 12, 629607. doi: 10.3389/fphar.2021.629607 PMID: 33912046
  195. Shareef, M.I.; Leelavathi, S.; Gopinath, S.M. Evaluation of in-vivo activity of Clerodendrum serratum L. against rheumatism. Int. J. Innov. Res. Technol., 2013, 2(12), 7750-7758.
  196. Singh, S.; Singh, T.G.; Mahajan, K.; Dhiman, S. Medicinal plants used against various inflammatory biomarkers for the management of rheumatoid arthritis. J. Pharm. Pharmacol., 2020, 72(10), 1306-1327. doi: 10.1111/jphp.13326 PMID: 32812250
  197. Venkatesha, S.H.; Dudics, S.; Astry, B.; Moudgil, K.D. Control of autoimmune inflammation by Celastrol, a natural triterpenoid. Pathog. Dis., 2016, 74(6), 1-2. doi: 10.1093/femspd/ftw059
  198. Busbee, P.B.; Rouse, M.; Nagarkatti, M.; Nagarkatti, P.S. Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders. Nutr. Rev., 2013, 71(6), 353-369. doi: 10.1111/nure.12024 PMID: 23731446
  199. Che, C.T.; Wong, M.; Lam, C. Natural products from Chinese Medicines with potential benefits to bone health. Molecules, 2016, 21(3), 239. doi: 10.3390/molecules21030239 PMID: 26927052
  200. Wu, C.H.; Lin, M.C.; Wang, H.C.; Yang, M.Y.; Jou, M.J.; Wang, C.J. Rutin inhibits oleic acid induced lipid accumulation via reducing lipogenesis and oxidative stress in hepatocarcinoma cells. J. Food Sci., 2011, 76(2), T65-T72. doi: 10.1111/j.1750-3841.2010.02033.x PMID: 21535797
  201. Hosseinzadeh, H.; Nassiri-Asl, M. Review of the protective effects of rutin on the metabolic function as an important dietary flavonoid. J. Endocrinol. Invest., 2014, 37(9), 783-788. doi: 10.1007/s40618-014-0096-3 PMID: 24879037
  202. Tian, R.; Yang, W.; Xue, Q.; Gao, L.; Huo, J.; Ren, D.; Chen, X. Rutin ameliorates diabetic neuropathy by lowering plasma glucose and decreasing oxidative stress via Nrf2 signaling pathway in rats. Eur. J. Pharmacol., 2016, 771, 84-92. doi: 10.1016/j.ejphar.2015.12.021 PMID: 26688570
  203. Tejada, S.; Pinya, S.; Martorell, M.; Capó, X.; Tur, J.A.; Pons, A.; Sureda, A. Potential anti-inflammatory effects of Hesperidin from the genus Citrus. Curr. Med. Chem., 2019, 25(37), 4929-4945. doi: 10.2174/0929867324666170718104412 PMID: 28721824
  204. Peng, P.; Jin, J.; Zou, G.; Sui, Y.; Han, Y.; Zhao, D.; Liu, L. Hesperidin prevents hyperglycemia in diabetic rats by activating the insulin receptor pathway. Exp. Ther. Med., 2020, 21(1), 53. doi: 10.3892/etm.2020.9485 PMID: 33273981
  205. Pinho-Ribeiro, F.A.; Zarpelon, A.C.; Mizokami, S.S.; Borghi, S.M.; Bordignon, J.; Silva, R.L.; Cunha, T.M.; Alves-Filho, J.C.; Cunha, F.Q.; Casagrande, R.; Verri, W.A., Jr The citrus flavonone naringenin reduces lipopolysaccharide-induced inflammatory pain and leukocyte recruitment by inhibiting NF-κB activation. J. Nutr. Biochem., 2016, 33, 8-14. doi: 10.1016/j.jnutbio.2016.03.013 PMID: 27260463
  206. Bussmann, A.J.C.; Borghi, S.M.; Zaninelli, T.H.; dos Santos, T.S.; Guazelli, C.F.S.; Fattori, V.; Domiciano, T.P.; Pinho-Ribeiro, F.A.; Ruiz-Miyazawa, K.W.; Casella, A.M.B.; Vignoli, J.A.; Camilios-Neto, D.; Casagrande, R.; Verri, W.A., Jr The citrus flavanone naringenin attenuates zymosan-induced mouse joint inflammation: Induction of Nrf2 expression in recruited CD45+ hematopoietic cells. Inflammopharmacology, 2019, 27(6), 1229-1242. doi: 10.1007/s10787-018-00561-6 PMID: 30612217
  207. Wang, J.R.; Li, T.Z.; Wang, C.; Li, S.M.; Luo, Y.H.; Piao, X.J.; Feng, Y.C.; Zhang, Y.; Xu, W.T.; Zhang, Y.; Zhang, T.; Wang, S.N.; Xue, H.; Wang, H.X.; Cao, L.K.; Jin, C.H. Liquiritin inhibits proliferation and induces apoptosis in HepG2 hepatocellular carcinoma cells via the ROS-mediated MAPK/AKT/NF-κB signaling pathway. Naunyn Schmiedebergs Arch. Pharmacol., 2020, 393(10), 1987-1999. doi: 10.1007/s00210-019-01763-7 PMID: 31956937
  208. Ni, H.; Xu, M.; Xie, K.; Fei, Y.; Deng, H.; He, Q.; Wang, T.; Liu, S.; Zhu, J.; Xu, L.; Yao, M. Liquiritin alleviates pain through inhibiting CXCL 1/CXCR 2 signaling pathway in bone cancer pain rat. Front. Pharmacol., 2020, 11, 436. doi: 10.3389/fphar.2020.00436 PMID: 32390832
  209. Hu, Y.; Li, J.; Qin, L.; Cheng, W.; Lai, Y.; Yue, Y.; Ren, P.; Pan, X.; Zhang, P. Study in treatment of collagen-induced arthritis in DBA/1 mice model by Genistein. Curr. Pharm. Des., 2017, 22(46), 6975-6981. doi: 10.2174/1381612822666161025150403 PMID: 27784235
  210. Haleagrahara, N.; Miranda-Hernandez, S.; Alim, M.A.; Hayes, L.; Bird, G.; Ketheesan, N. Therapeutic effect of quercetin in collagen-induced arthritis. Biomed. Pharmacother., 2017, 90, 38-46. doi: 10.1016/j.biopha.2017.03.026 PMID: 28342364
  211. Jiang, P.Y.; Zhu, X.J.; Zhang, Y.N.; Zhou, F.F.; Yang, X.F. Protective effects of apigenin on LPS-induced endometritis via activating Nrf2 signaling pathway. Microb. Pathog., 2018, 123, 139-143. doi: 10.1016/j.micpath.2018.06.031 PMID: 29928944
  212. Yang, H.; Huang, J.; Mao, Y.; Wang, L.; Li, R.; Ha, C. Vitexin alleviates interleukin-1β-induced inflammatory responses in chondrocytes from osteoarthritis patients: Involvement of HIF-1α pathway. Scand. J. Immunol., 2019, 90(2), e12773. doi: 10.1111/sji.12773 PMID: 31055848
  213. Wang, Y.; Gao, J.; Xing, L.Z. Therapeutic potential of Oroxylin A in rheumatoid arthritis. Int. Immunopharmacol., 2016, 40, 294-299. doi: 10.1016/j.intimp.2016.09.006 PMID: 27643663
  214. Lee, J.Y.; Park, W. Anti-inflammatory effects of oroxylin A on RAW 264.7 mouse macrophages induced with polyinosinic-polycytidylic acid. Exp. Ther. Med., 2016, 12(1), 151-156. doi: 10.3892/etm.2016.3320 PMID: 27347031
  215. Yang, J.; Yang, X.; Chu, Y.; Li, M. Identification of baicalin as an immunoregulatory compound by controlling TH17 cell differentiation. PLoS ONE, 2011, 6(2), e17164. doi: 10.1371/journal.pone.0017164
  216. Yang, X.; Yang, J.; Zou, H. Baicalin inhibits IL-17-mediated joint inflammation in murine adjuvant-induced arthritis. Clin. Dev. Immunol., 2013, 2013, 1-8. doi: 10.1155/2013/268065 PMID: 23840239
  217. Chi, L.; Gao, W.; Shu, X.; Lu, X. A natural flavonoid glucoside, icariin, regulates Th17 and alleviates rheumatoid arthritis in a murine model. Mediators Inflamm., 2014, 2014, 1-10. doi: 10.1155/2014/392062 PMID: 25374443
  218. Wang, W.; Sun, W.; Jin, L. Caffeic acid alleviates inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes by inhibiting phosphorylation of IκB kinase α/β and IκBα. Int. Immunopharmacol., 2017, 48, 61-66. doi: 10.1016/j.intimp.2017.04.025 PMID: 28463788
  219. Yang, C.M.; Chen, Y.W.; Chi, P.L.; Lin, C.C.; Hsiao, L.D. Resveratrol inhibits BK-induced COX-2 transcription by suppressing acetylation of AP-1 and NF-κB in human rheumatoid arthritis synovial fibroblasts. Biochem. Pharmacol., 2017, 132, 77-91. doi: 10.1016/j.bcp.2017.03.003 PMID: 28288820
  220. Sharma, K.; Sahoo, J. Chromatographic determination of curcumin in the presence of its degradation products by HPLC. Int. J. Pharm. Pharm. Sci., 2020, 11(5), 2342-2349. doi: 10.13040/ijpsr.0975-8232.11(5)
  221. Lende, A.B.; Kshirsagar, A.D.; Deshpande, A.D.; Muley, M.M.; Patil, R.R.; Bafna, P.A.; Naik, S.R. Anti-inflammatory and analgesic activity of protocatechuic acid in rats and mice. Inflammopharmacology, 2011, 19(5), 255-263. doi: 10.1007/s10787-011-0086-4 PMID: 21748471
  222. Kwak, S.C.; Lee, C.; Kim, J.Y.; Oh, H.M.; So, H.S.; Lee, M.S.; Rho, M.C.; Oh, J. Chlorogenic acid inhibits osteoclast differentiation and bone resorption by down-regulation of receptor activator of nuclear factor kappa-B ligand-induced nuclear factor of activated T cells c1 expression. Biol. Pharm. Bull., 2013, 36(11), 1779-1786. doi: 10.1248/bpb.b13-00430 PMID: 23985829
  223. Liu, W.; Zhang, Y.; Zhu, W.; Ma, C.; Ruan, J.; Long, H.; Wang, Y. Sinomenine inhibits the progression of rheumatoid arthritis by regulating the secretion of inflammatory cytokines and monocyte/macrophage subsets. Front. Immunol., 2018, 9, 2228. doi: 10.3389/fimmu.2018.02228 PMID: 30319663
  224. Ma, A.; Yang, Y.; Wang, Q.; Wang, Y.; Wen, J.; Zhang, Y. Anti-inflammatory effects of oxymatrine on rheumatoid arthritis in rats via regulating the imbalance between Treg and Th17 cells. Mol. Med. Rep., 2017, 15(6), 3615-3622. doi: 10.3892/mmr.2017.6484 PMID: 28440447
  225. Farinon, M.; Clarimundo, V.S.; Pedrazza, G.P.R.; Gulko, P.S.; Zuanazzi, J.A.S.; Xavier, R.M.; de Oliveira, P.G. Disease modifying anti-rheumatic activity of the alkaloid montanine on experimental arthritis and fibroblast-like synoviocytes. Eur. J. Pharmacol., 2017, 799, 180-187. doi: 10.1016/j.ejphar.2017.02.013 PMID: 28192100
  226. Golbahari, S.; Abtahi Froushani, S.M. Synergistic benefits of Nicotine and Thymol in alleviating experimental rheumatoid arthritis. Life Sci., 2019, 239, 117037. doi: 10.1016/j.lfs.2019.117037 PMID: 31730863
  227. Yang, J.; Cai, H.D.; Zeng, Y.L.; Chen, Z.H.; Fang, M.H.; Su, Y.P.; Huang, H.H.; Xu, Y.; Yu, C.X. Effects of koumine on adjuvant- and collagen-induced arthritis in rats. J. Nat. Prod., 2016, 79(10), 2635-2643. doi: 10.1021/acs.jnatprod.6b00554 PMID: 27657857
  228. Wang, X.; He, X.; Zhang, C.F.; Guo, C.R.; Wang, C.Z.; Yuan, C.S. Anti-arthritic effect of berberine on adjuvant-induced rheumatoid arthritis in rats. Biomed. Pharmacother., 2017, 89, 887-893. doi: 10.1016/j.biopha.2017.02.099 PMID: 28282791
  229. Chen, Q.; Zhu, L.; Yip, K.M.; Tang, Y.; Liu, Y.; Jiang, T.; Zhang, J.; Zhao, Z.; Yi, T.; Chen, H. A hybrid platform featuring nanomagnetic ligand fishing for discovering COX-2 selective inhibitors from aerial part of Saussurea laniceps Hand.-. Mazz. J. Ethnopharmacol., 2021, 271, 113849. doi: 10.1016/j.jep.2021.113849 PMID: 33485983
  230. Xu, R.; Liu, Z.; Hou, J.; Huang, T.; Yang, M. Osthole improves collagen-induced arthritis in a rat model through inhibiting inflammation and cellular stress. Cell. Mol. Biol. Lett., 2018, 23(1), 19. doi: 10.1186/s11658-018-0086-0 PMID: 29743895
  231. Hsia, C.W.; Lin, K.C.; Lee, T.Y.; Hsia, C.H.; Chou, D.S.; Jayakumar, T.; Velusamy, M.; Chang, C.C.; Sheu, J.R. Esculetin, a coumarin derivative, prevents thrombosis: Inhibitory signaling on PLCγ2–PKC–AKT activation in human platelets. Int. J. Mol. Sci., 2019, 20(11), 2731. doi: 10.3390/ijms20112731 PMID: 31163690
  232. Liang, C.; Ju, W.; Pei, S.; Tang, Y.; Xiao, Y. Pharmacological activities and synthesis of esculetin and its derivatives: A mini-review. Molecules, 2017, 22(3), 387. doi: 10.3390/molecules22030387 PMID: 28257115
  233. Gao, Q.; Shan, J.; Di, L.; Jiang, L.; Xu, H. Therapeutic effects of daphnetin on adjuvant-induced arthritic rats. J. Ethnopharmacol., 2008, 120(2), 259-263. doi: 10.1016/j.jep.2008.08.031 PMID: 18835428
  234. Tu, L.; Li, S.; Fu, Y.; Yao, R.; Zhang, Z.; Yang, S.; Zeng, X.; Kuang, N. The therapeutic effects of daphnetin in collagen-induced arthritis involve its regulation of Th17 cells. Int. Immunopharmacol., 2012, 13(4), 417-423. doi: 10.1016/j.intimp.2012.04.001 PMID: 22554834
  235. Deng, H.; Zheng, M.; Hu, Z.; Zeng, X.; Kuang, N.; Fu, Y. Effects of daphnetin on the autophagy signaling pathway of fibroblast-like synoviocytes in rats with collagen-induced arthritis (CIA) induced by TNF-α. Cytokine, 2020, 127, 154952. doi: 10.1016/j.cyto.2019.154952 PMID: 31865066
  236. Xu, L.; Yu, Y.; Sang, R.; Li, J.; Ge, B.; Zhang, X. Protective effects of taraxasterol against ethanol-induced liver injury by regulating CYP2E1/Nrf2/HO-1 and NF-kB signaling pathways in mice. Oxid. Med. Cell. Longev., 2018, 2018, 1-11. doi: 10.1155/2018/8284107 PMID: 30344887
  237. Yu, W.G.; Shen, Y.; Wu, J.Z.; Gao, Y.B.; Zhang, L.X. Madecassoside impedes invasion of rheumatoid fibroblast-like synoviocyte from adjuvant arthritis rats via inhibition of NF- κ B-mediated matrix metalloproteinase-13 expression. Chin. J. Nat. Med., 2018, 16(5), 330-338. doi: 10.1016/S1875-5364(18)30064-5 PMID: 29860993
  238. Fukumitsu, S.; Villareal, M.O.; Fujitsuka, T.; Aida, K.; Isoda, H. Anti-inflammatory and anti-arthritic effects of pentacyclic triterpenoids maslinic acid through NF-κB inactivation. Mol. Nutr. Food Res., 2016, 60(2), 399-409. doi: 10.1002/mnfr.201500465 PMID: 26499467
  239. Mussard, E.; Cesaro, A.; Lespessailles, E.; Legrain, B.; Berteina-Raboin, S.; Toumi, H. Andrographolide, A natural antioxidant: An Update. Antioxidants, 2019, 8(12), 571. doi: 10.3390/antiox8120571
  240. Chen, S.R.; Dai, Y.; Zhao, J.; Lin, L.; Wang, Y.; Wang, Y. A mechanistic overview of Triptolide and Celastrol, natural products from Tripterygium wilfordii Hook F. Front. Pharmacol., 2018, 9, 104. doi: 10.3389/fphar.2018.00104 PMID: 29491837
  241. Kusunoki, N.; Yamazaki, R.; Kitasato, H.; Beppu, M.; Aoki, H.; Kawai, S. Triptolide, an active compound identified in a traditional Chinese herb, induces apoptosis of rheumatoid synovial fibroblasts. BMC Pharmacol., 2004, 4(1), 2. doi: 10.1186/1471-2210-4-2 PMID: 15040811
  242. Kong, X.; Zhang, Y.; Liu, C.; Guo, W.; Li, X.; Su, X.; Wan, H.; Sun, Y.; Lin, N. Anti-angiogenic effect of triptolide in rheumatoid arthritis by targeting angiogenic cascade. PLoS ONE, 2013, 8(10), e77513. doi: 10.1371/journal.pone.0077513
  243. Li, F.; Li, H.; Luo, S.; Ran, Y.; Xie, X.; Wang, Y.; Zheng, M.; Wang, M.; Zhao, Z.; Li, X. Evaluation of the effect of andrographolide and methotrexate combined therapy in complete Freundʼs adjuvant induced arthritis with reduced hepatotoxicity. Biomed. Pharmacother., 2018, 106, 637-645. doi: 10.1016/j.biopha.2018.07.001 PMID: 29990853
  244. Wang, Y.; Zhou, C.; Gao, H.; Li, C.; Li, D.; Liu, P.; Huang, M.; Shen, X.; Liu, L. Therapeutic effect of Cryptotanshinone on experimental rheumatoid arthritis through downregulating p300 mediated-STAT3 acetylation. Biochem. Pharmacol., 2017, 138, 119-129. doi: 10.1016/j.bcp.2017.05.006 PMID: 28522406
  245. Xia, G.; Wang, X.; Sun, H.; Qin, Y.; Fu, M. Carnosic acid (CA) attenuates collagen-induced arthritis in db/db mice via inflammation suppression by regulating ROS-dependent p38 pathway. Free Radic. Biol. Med., 2017, 108, 418-432. doi: 10.1016/j.freeradbiomed.2017.03.023 PMID: 28343998
  246. Chen, J.J.; Ting, C.W.; Wu, Y.C.; Hwang, T.L.; Cheng, M.J.; Sung, P.J.; Wang, T.C.; Chen, J.F. New Labdane-type diterpenoids and anti-inflammatory constituents from Hedychium coronarium. Int. J. Mol. Sci., 2013, 14(7), 13063-13077. doi: 10.3390/ijms140713063 PMID: 23799360
  247. Bert, J.; Mahowald, M.L.; Frizelle, S.; Dorman, C.W.; Funkenbusch, S.C.; Krug, H.E. The effect of treatment with Resiniferatoxin and Capsaicin on dynamic weight bearing measures and evoked pain responses in a chronic inflammatory arthritis murine model. Intern. Med. Rev., 2016, 2(6), 1-14. doi: 10.18103/imr.v0i6.89 PMID: 27774522
  248. Srivastava, S.; Lal, V.K.; Pant, K.K. Polyherbal formulations based on Indian medicinal plants as antidiabetic phytotherapeutics. Phytopharmacology, 2013, 2, 1-15.
  249. Spinella, M. The importance of pharmacological synergy in psychoactive herbal medicines. Altern. Med. Rev., 2002, 7(2), 130-137. PMID: 11991792
  250. Pal, R.S.; Pal, Y.; Wal, P.; Wal, A. Standardization and detailed aspects of Chopchinyadi churna: A potent anti-arthritic medicine. Open Med. J., 2019, 6(1), 19-25. doi: 10.2174/1874220301906010019
  251. Subash, K.R.; Cheriyan, B.; Parvathavarthini, S.; Bhaarati, G.M.; Venugopal, V. Effect of polyherbal formulation Rumalaya Forte on adjuvant induced arthritis in rats. Indian Drugs, 2012, 49(10), 18-24. doi: 10.53879/id.49.10.p0018
  252. Balkrishna, A.; Sakat, S.S.; Joshi, K.; Paudel, S.; Joshi, D.; Joshi, K.; Ranjan, R.; Gupta, A.; Bhattacharya, K.; Varshney, A. Herbo-mineral formulation ‘Ashwashila’ attenuates rheumatoid arthritis symptoms in collagen-antibody-induced arthritis (CAIA) mice model. Sci. Rep., 2019, 9(1), 8025. doi: 10.1038/s41598-019-44485-9 PMID: 31142786
  253. Sumanth, M.; Swetha, A. Elucidation of mechanism of anti-arthritic action of Arthosansar-a polyherbal formulation. Indian J. Tradit. Knowl., 2012, 11(4), 704-713.
  254. Chakradhar, S.N.; Kanaka, B.M.; Sangeetha, S. Herbal medicines and formulation approaches for the treatment of arthritis. Drug Invent. Today, 2010, 10, 1617-1625.
  255. Singh, S.; Nair, V.; Gupta, Y.K. Antiarthritic activity of majoon suranjan (a polyherbal Unani formulation) in rat. Indian J. Med. Res., 2011, 134(3), 384-388. PMID: 21985823
  256. Da Silva, M.D.; Guginski, G.; Werner, M.F. de P.; Baggio, C.H.; Marcon, R.; Santos, A.R.S. Involvement of interleukin-10 in the anti-inflammatory effect of sanyinjiao (SP6) acupuncture in a mouse model of peritonitis. Evid. Based Complementary. Altern. Med., 2011, 2011, 217946. doi: 10.1093/ecam/neq036
  257. Xue, L.M.; Zhang, Q.Y.; Han, P.; Jiang, Y.P.; Yan, R.D.; Wang, Y.; Rahman, K.; Jia, M.; Han, T.; Qin, L.P. Hepatotoxic constituents and toxicological mechanism of Xanthium strumarium L. fruits. J. Ethnopharmacol., 2014, 152(2), 272-282. doi: 10.1016/j.jep.2013.12.024 PMID: 24447814
  258. Marrelli, M.; Amodeo, V.; Statti, G.; Conforti, F. Biological properties and bioactive components of Allium cepa L.: Focus on potential benefits in the treatment of obesity and related comorbidities. Molecules, 2018, 24(1), 119. doi: 10.3390/molecules24010119 PMID: 30598012
  259. Guo, X.; Mei, N. Aloe vera: A review of toxicity and adverse clinical effects. J. Environ. Sci. Health Part C Environ. Carcinog. Ecotoxicol. Rev., 2016, 34(2), 77-96. doi: 10.1080/10590501.2016.1166826 PMID: 26986231
  260. Worakunphanich, W.; Thavorncharoensap, M.; Youngkong, S.; Thadanipon, K.; Thakkinstian, A. Safety of Andrographis paniculata: A systematic review and meta-analysis. Pharmacoepidemiol. Drug Saf., 2021, 30(6), 727-739. doi: 10.1002/pds.5190 PMID: 33372366
  261. Nazari, S.; Rameshrad, M.; Hosseinzadeh, H. Toxicological effects of Glycyrrhiza glabra (Licorice): A review. Phytother. Res., 2017, 31(11), 1635-1650. doi: 10.1002/ptr.5893 PMID: 28833680
  262. Bello, I.; Bakkouri, A.; Tabana, Y.; Al-Hindi, B.; Al-Mansoub, M.; Mahmud, R.; Asmawi, M. Acute and sub-acute toxicity evaluation of the methanolic extract of Alstonia scholaris stem bark. Med. Sci., 2016, 4(1), 4. doi: 10.3390/medsci4010004 PMID: 29083368
  263. Thomas, T.J.; Panikkar, B.; Subramoniam, A.; Nair, M.K.; Panikkar, K.R. Antitumour property and toxicity of Barringtonia racemosa Roxb seed extract in mice. J. Ethnopharmacol., 2002, 82(2-3), 223-227. doi: 10.1016/S0378-8741(02)00074-0 PMID: 12241999
  264. Parasuraman, S.; Thing, G.; Dhanaraj, S. Polyherbal formulation: Concept of ayurveda. Pharmacogn. Rev., 2014, 8(16), 73-80. doi: 10.4103/0973-7847.134229 PMID: 25125878

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers